GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GFC Life Science Co Ltd (XKRX:388610) » Definitions » EBITDA Margin %

GFC Life Science Co (XKRX:388610) EBITDA Margin % : -15.80% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is GFC Life Science Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. GFC Life Science Co's EBITDA for the six months ended in Dec. 2024 was ₩-2,656 Mil. GFC Life Science Co's Revenue for the six months ended in Dec. 2024 was ₩16,805 Mil. Therefore, GFC Life Science Co's EBITDA margin for the quarter that ended in Dec. 2024 was -15.80%.


GFC Life Science Co EBITDA Margin % Historical Data

The historical data trend for GFC Life Science Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GFC Life Science Co EBITDA Margin % Chart

GFC Life Science Co Annual Data
Trend Dec23 Dec24
EBITDA Margin %
33.73 -15.80

GFC Life Science Co Semi-Annual Data
Dec23 Dec24
EBITDA Margin % 33.73 -15.80

Competitive Comparison of GFC Life Science Co's EBITDA Margin %

For the Biotechnology subindustry, GFC Life Science Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GFC Life Science Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GFC Life Science Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where GFC Life Science Co's EBITDA Margin % falls into.


;
;

GFC Life Science Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

GFC Life Science Co's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-2655.507/16804.534
=-15.80 %

GFC Life Science Co's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-2655.507/16804.534
=-15.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GFC Life Science Co  (XKRX:388610) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


GFC Life Science Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of GFC Life Science Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


GFC Life Science Co Business Description

Traded in Other Exchanges
N/A
Address
823, Dongtansunhwan-daero, 17th Floor, Gyeonggi-do, Hwaseong-si, KOR
GFC Life Science Co Ltd develops innovative cosmetics using a variety of sources. The company's ingredients specialize in human biotechnology, Bio-Phytochemistry, research of Bio-Fermentation, Unique Bio-Technology, anti-pollution material, and powder transfer technology.

GFC Life Science Co Headlines

No Headlines